One MASSIVE thing about Tesla and Afterpay that people forget

Darling growth companies are often derided for bleeding cash. But is that actually true? A fundie offers his thoughts.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Tesla Inc (NASDAQ: TSLA) is often cited as the poster child for the irrational exuberance of retail investors.

Notwithstanding the COVID-19 market crash, the stock for the electric car maker has increased 660% times since the start of 2020.

That dizzying ascent has made many people rich. This includes chief executive Elon Musk, who in January briefly overtook Amazon.com Inc (NASDAQ: AMZN) founder Jeff Bezos as the planet's wealthiest person.

Tesla is now worth more than the 8 biggest traditional car makers combined, even though it produces a fraction of the vehicles they do.

Critics say this is the worst example of an overvalued growth stock. Foolhardy retail investors are pumping money into speculative businesses that are just bleeding cash, they say.

The local version of Tesla is Afterpay Ltd (ASX: APT), which jumped 5-fold in price from the start of 2020 to February this year.

So is the criticism of these businesses valid?

A businessman lights up the fifth star in a lineup, indicating positive share price for a top performer

Image source: Getty Images

Tesla's had positive earnings for 3 years

Frazis Capital portfolio manager Michael Frazis pointed out a tidbit that the Tesla critics seem to have missed.

"In the industry, it seems nobody really knows this or really wants to engage with the fact this company's been profitable for a long time," he told clients in a video briefing.

When Frazis says "profitable", he refers to the EBITDA, which has been in the black for the last 3 financial years.

The 2020 financial year saw Tesla generate US$4.3 billion in EBITDA, up 93% on the year before. The car maker even made its first net profit of US$690 million.

Back in 2019, before the massive share price surge, Tesla was an absolute bargain.

"A couple of years ago, this was trading 15 times [enterprise value to] EBITDA. It was basically a value stock!"

The same situation applied to Afterpay when Frazis' fund bought into it back in 2016.

"It was profitable then. A huge cash draw, but it was profitable."

What should growth companies do with all that EBITDA

The growth stocks Frazis favours will put all that positive EBITDA back into the business.

"What we want to see is these companies investing all that profit."

He cited the examples of fintechs Xero Limited (ASX: XRO) and Square Inc (NYSE: SQ) as other businesses where investment back into the business saw their revenues take off.

"In Q1 2015, [Square] spent US$32 million and got US$172 million back in gross profit," said Frazis.

"This is the dynamic we look for. I wouldn't get lost in 'do we care about profitability' – of course we do, but it's beside the point."

Hyperion Asset Management lead portfolio manager Jason Orthman said much the same last month in support of Tesla and Square.

They are actually his fund's largest current holdings.

"Even though those share prices have re-rated upwards as we were buying them over the last 12 months or so, we still believe that they're fundamentally misunderstood and there's a large shift in consumer behaviour going on," Orthman told The Motley Fool.

"So it's still really day one for both Tesla and Square."

Tony Yoo owns shares of AFTERPAY T FPO, Square, and Xero. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of and recommends Square and Tesla. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of Xero. The Motley Fool Australia owns shares of AFTERPAY T FPO. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Growth Shares

Cropped shot of a young female scientist working on her computer in the laboratory.
Healthcare Shares

Could Telix shares be a millionaire-maker stock?

Telix looks a compelling growth story, with brokers eyeing more than 150% upside.

Read more »

Person pointing at an increasing blue graph which represents a rising share price.
Growth Shares

2 top ASX shares I'd buy right now in this March madness

The valuations these businesses are now trading at are too good to ignore!

Read more »

A man has a surprised and relieved expression on his face.
Growth Shares

3 undervalued ASX stocks to consider buying immediately

Analysts are tipping huge upsides ahead for these undervalued shares.

Read more »

Man jumps for joy in front of a background of a rising stocks graphic.
Healthcare Shares

3 ASX healthcare stocks tipped to soar over 100% higher this year

These ASX shares are on my radar this week.

Read more »

A female ASX investor looks through a magnifying glass that enlarges her eye and holds her hand to her face with her mouth open as if looking at something of great interest or surprise.
Growth Shares

2 ASX growth stocks down 40% to 60% to buy now

Big sell-offs can sometimes create compelling investment opportunities.

Read more »

Red buy button on an Apple keyboard with a finger on it.
Growth Shares

Brokers rate these 2 top ASX shares as buys in March

Here’s why experts are confident about these businesses for the long-term.

Read more »

Man rocketing in the sky.
Growth Shares

1 ASX growth stock that could skyrocket in 2026 and beyond

Many brokers see the pullback as an opportunity, tipping triple-digit upside.

Read more »

people lined up and using smart phones and laptops
Growth Shares

Life360 and two ASX 200 shares for smart investors to buy

Let's see why it could be a good idea to buy and hold these shares.

Read more »